NO894573D0 - Rekombinante interleukin-2 hybridproteiner. - Google Patents

Rekombinante interleukin-2 hybridproteiner.

Info

Publication number
NO894573D0
NO894573D0 NO894573A NO894573A NO894573D0 NO 894573 D0 NO894573 D0 NO 894573D0 NO 894573 A NO894573 A NO 894573A NO 894573 A NO894573 A NO 894573A NO 894573 D0 NO894573 D0 NO 894573D0
Authority
NO
Norway
Prior art keywords
hybrid proteins
recombinant interleukin
interleukin
recombinant
proteins
Prior art date
Application number
NO894573A
Other languages
English (en)
Other versions
NO894573L (no
Inventor
Grace W Ju
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO894573D0 publication Critical patent/NO894573D0/no
Publication of NO894573L publication Critical patent/NO894573L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
NO89894573A 1988-11-17 1989-11-16 Rekombinante interleukin-2 hybridproteiner. NO894573L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27235688A 1988-11-17 1988-11-17

Publications (2)

Publication Number Publication Date
NO894573D0 true NO894573D0 (no) 1989-11-16
NO894573L NO894573L (no) 1990-05-18

Family

ID=23039446

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89894573A NO894573L (no) 1988-11-17 1989-11-16 Rekombinante interleukin-2 hybridproteiner.

Country Status (13)

Country Link
EP (1) EP0369316A3 (no)
JP (1) JPH02273193A (no)
AU (1) AU4474589A (no)
CA (1) CA2002854A1 (no)
DK (1) DK570589A (no)
FI (1) FI895456A0 (no)
HU (1) HUT52154A (no)
IL (1) IL92316A0 (no)
MC (1) MC2072A1 (no)
NO (1) NO894573L (no)
PT (1) PT92335A (no)
YU (1) YU219289A (no)
ZA (1) ZA898139B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE123065T1 (de) * 1989-07-07 1995-06-15 Takeda Chemical Industries Ltd Proteine und deren herstellung.
FR2653020B1 (fr) * 1989-10-17 1993-03-26 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des leucemies.
US5238823A (en) * 1990-08-22 1993-08-24 Veterinary Infectious Disease Organization Interleukin-2-leukotoxin gene fusions and uses thereof
US5273889A (en) * 1990-08-22 1993-12-28 University Of Saskatchewan Gamma-iterferon-leukotoxin gene fusions and uses thereof
US5594107A (en) * 1990-08-22 1997-01-14 University Of Saskatchewan Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
EP0547163B1 (en) * 1990-08-29 2002-02-06 Centre Hospitalier Regional De Nantes Protein polyligands joined to a stable protein core
US5571507A (en) * 1992-02-25 1996-11-05 Seragen, Inc. Methods of treating diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210634A (en) * 1983-12-23 1989-05-29 Hoffmann La Roche Purification of recombinant human interleukin - 2; pharmaceutical compositions
DE3537461A1 (de) * 1985-10-22 1987-04-23 Hoechst Ag Derivat des interleukin-2, seine herstellung und verwendung
US4892827A (en) * 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects

Also Published As

Publication number Publication date
DK570589A (da) 1990-05-18
NO894573L (no) 1990-05-18
HUT52154A (en) 1990-06-28
JPH02273193A (ja) 1990-11-07
EP0369316A3 (en) 1990-11-22
EP0369316A2 (en) 1990-05-23
ZA898139B (en) 1990-08-29
AU4474589A (en) 1990-05-24
HU895908D0 (en) 1990-02-28
YU219289A (en) 1991-10-31
DK570589D0 (da) 1989-11-14
PT92335A (pt) 1990-05-31
IL92316A0 (en) 1990-07-26
MC2072A1 (fr) 1990-10-03
CA2002854A1 (en) 1990-05-17
FI895456A0 (fi) 1989-11-16

Similar Documents

Publication Publication Date Title
FI892714A (fi) Rekombinant-coccidiosisvaccin.
FI895860A0 (fi) Nya benzoesyra- och fenylaettiksyraderivat.
DE3851238T2 (de) Antikoagulierende Peptide.
DE3888921D1 (de) Polypeptide.
FI892423A0 (fi) Nya polyanhydrider.
DE3683186D1 (de) Rekombinantes humaninterleukin-1.
NO892294D0 (no) Polypeptidforbindelser.
NO881384D0 (no) Peptider.
NO885108L (no) Peptider.
FI892993A0 (fi) Nya amidino- och guanidinofoereningar.
NO894573L (no) Rekombinante interleukin-2 hybridproteiner.
DK395288D0 (da) Proteiner
FI893451A (fi) Nya proteiner.
NO890174D0 (no) Rekombinante interleukin-1alfa-polypeptider.
NO892948L (no) Modifiserte proteiner.
IT8523165A0 (it) Peptidi correlati al lisozima.
FI890695A0 (fi) Nya aspartattranskarbamylas -inhibitorer.
FI891640A (fi) Nya foereningar.
NO872386L (no) Peptider.
FI893708A (fi) Nya cyklodextringlykosyltransferaser.
NO875477D0 (no) Rekombinant alveolaert overflateaktivt protein.
FI901216A0 (fi) Nya androstanderivat.
DE68914057D1 (de) Peptide.
NO900470D0 (no) Hybride proteiner.
NO910981D0 (no) Peptidforbindelser.